Extrapyramidal system

Zen Magnets and Neoballs Magnets Recalled Due to Ingestion Hazard

Retrieved on: 
Martedì, Agosto 17, 2021
Online, Smoke, Extrapyramidal system, Gold, Death, Commission, Sepsis, Magnet, U.S. Consumer Product Safety Commission, Injury, URL, Infection, Silver, Safety, CPSC, Human

Consumers should immediately stop using the recalled magnets and contact Zen Magnets LLC for a refund.

Key Points: 
  • Consumers should immediately stop using the recalled magnets and contact Zen Magnets LLC for a refund.
  • Description: This mandatory recall involves all Zen Magnets and Neoballs magnets.
  • Zen Magnets and Neoballs are high-powered 5 mm spherical magnets.
  • Incidents/Injuries: Zen Magnets LLC is aware of two children who ingested Zen Magnets and required surgery to remove the magnets and parts of their intestines and bowels.

Ingestion of High-Powered Magnetic Balls and Magnetic Cubes Poses Serious Risk of Severe Internal Injury or Death in Children and Teens

Retrieved on: 
Martedì, Agosto 17, 2021
Extrapyramidal system, Death, Vomiting, Pain scale, Commission, Sepsis, Mouth, Nausea, U.S. Consumer Product Safety Commission, X-ray, Injury, Child, Infection, Caustic ingestion, Safety, Nose, Magnet, Caregiver, Diarrhea, CPSC, Parent, Toy, Medical imaging, Dietary supplement

Today, the CPSC announced a mandatory recall of 10 million Zen and Neoballs magnets due to an ingestion hazard and risk of death.

Key Points: 
  • Today, the CPSC announced a mandatory recall of 10 million Zen and Neoballs magnets due to an ingestion hazard and risk of death.
  • This can result in perforations, twisting and/or blockage of the intestines, infection, blood poisoning, and death.
  • In some cases, these and other symptoms may not appear until after serious internal injury has occurreddo not wait for symptoms.
  • To learn more about how and why magnetic balls are so dangerous to children, please go to www.cpsc.gov/Safety-Education/Safety-Education-Centers/Magnets .

Vitamin and Minerals Global Market Report 2021: COVID-19 Implications and Growth to 2030 - ResearchAndMarkets.com

Retrieved on: 
Giovedì, Agosto 12, 2021
Fitness & Nutrition, Health, Shijiazhuang Pharma Group, COVID-19, Mineral, IFPRI, Bread, Food, Immune system, Population, Powder, Infection, Acquisition, Amway, Vegetable, Farm, News, Health, Coronavirus, Vitamin, Nutrition, Segment, Daiichi Sankyo, Sanofi, Tablet, DSM, Livestock, GNC, Milk, COVID, Zinc, Micronutrient, Dairy, Application, Dietary supplement, Patient, Extrapyramidal system, International Food Policy Research Institute, Animal

The "Vitamin and Minerals Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vitamin and Minerals Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The disruptions in supply chains for the production of supplements are a key factor hampering the growth of the vitamins and mineral supplement market.
  • Therefore, disruptions in supply chains for nutrient-rich foods are expected to hinder the growth of the vitamins and mineral supplement market.
  • Global Vitamins and Mineral Supplement Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
    6.2.

Antibe Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference

Retrieved on: 
Lunedì, Agosto 9, 2021
Other Professional Services, Pharmaceutical, Finance, General Health, Health, Banking, Professional Services, Other Health, Hydrogen sulfide, Aspirin, Extrapyramidal system, Webcast, Antibe Therapeutics, News, TSX, Inflammatory bowel disease, Conference, OTCQX, Canaccord Genuity, Inflammation, Bleeding, Ulcer, Pharmaceutical industry

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions, today announced its participation in the Canaccord Genuity 41st Annual Growth Conference being held virtually on August 10 - 12.

Key Points: 
  • Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions, today announced its participation in the Canaccord Genuity 41st Annual Growth Conference being held virtually on August 10 - 12.
  • Following the presentation, a replay of the webcast will be available on the website for 90 days.
  • Antibe is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to address inflammation arising from a wide range of medical conditions.
  • The Companys next target is inflammatory bowel disease (IBD), a condition long in need of safer, more effective therapies.

EY Announces Tony Remington and Julie Brazil of Gravity Diagnostics as an Entrepreneur Of The Year® 2021 East Central Award Winner

Retrieved on: 
Venerdì, Agosto 6, 2021
Growth, Fortune 500, Ernst & Young, Ernst & Young Entrepreneur of the Year Award, Public health, LLC, CEO, LLP, COVID-19, Technology, Patient, PNC Financial Services, Courage, Blood, Sexually transmitted infection, University, COO, CLIA, Extrapyramidal system, Multimedia, Program, View, Central, City, Physician, Legislation, Entrepreneurship, EY, Argo, VRC, Remington, Argo AI, SAP, Wool, Pharmaceutical industry, Accounting

COVINGTON, Ky., Aug. 6, 2021 /PRNewswire/ --Ernst & Young LLP (EY US)announced yesterday that Tony Remington, CEO, and Julie Brazil, COO, of Gravity Diagnostics were named an Entrepreneur Of The Year 2021 East Central Award winner.

Key Points: 
  • COVINGTON, Ky., Aug. 6, 2021 /PRNewswire/ --Ernst & Young LLP (EY US)announced yesterday that Tony Remington, CEO, and Julie Brazil, COO, of Gravity Diagnostics were named an Entrepreneur Of The Year 2021 East Central Award winner.
  • Remington and Brazil were selected by an independent panel of judges, and the award was announced during the program's virtual awards celebration on August 5, 2021.
  • "Julie and I could not be more humbled to be named winners of such a prestigious award.
  • As East Central award winners, Remington and Brazil are now eligible for consideration for the Entrepreneur Of The Year 2021 National Awards.

Veterinary Antibiotics Global Market Report 2021: Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory, Premixes, Injections, Oral Powders, Oral Solutions - ResearchAndMarkets.com

Retrieved on: 
Venerdì, Agosto 6, 2021
Consumer, Health, Pets, Veterinary, Pharmaceutical, Growth, Campylobacter, Bacteria, Food, Zoonosis, Food chain, Extrapyramidal system, Parasitism, Union, Infection, CAGR, Bayer, COVID-19, Federal Food, Drug, and Cosmetic Act, Sale, Human, European Union, Animal, FDA, Boehringer Ingelheim, Salmonella, Pharmaceutical industry, Vaccine, Livestock

The "Veterinary Antibiotics Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Veterinary Antibiotics Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the veterinary antibiotics market are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly Company and Elanco.
  • The global veterinary antibiotics market is expected to grow from $1.12 billion in 2020 to $1.22 billion in 2021 at a compound annual growth rate (CAGR) of 8.9%.
  • The veterinary antibiotics market consists of sales of veterinary antibiotics and related services.